FIELD: medicine; pharmaceutics.
SUBSTANCE: invention relates to antibacterial compositions and can find application for treating bacterial infections caused by main multidrug-resistant gram-negative pathogens. Disclosed is use of the combination for treating bacterial infections, caused by the main multidrug-resistant gram-negative pathogens Escherichia coli, Enterobacter cloacae, Klebsiella pneumoniae, Proteus spp, Citrobacter freundii, Serratia marcescens, and/or Pseudomonas aeruginosa, producing variants of beta-lactamase ESBL types TEM, SHV and/or CTX-M, which is a mixture containing a cephalosporin antibiotic cefepime, a beta-lactamase inhibitor sulbactam and an enzyme inhibitor avibactam in ratio of 4:2:1 (wt.), respectively.
EFFECT: invention provides an increase in the effectiveness of the combination of antibiotics in relation to standard strains and clinical isolates of gram-negative pathogens, including polyresistant strains producing ESBL variants of TEM, SHV and CTX-M types.
1 cl, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR THE TREATMENT OF INFECTIONS CAUSED BY MULTI-RESISTANT BACTERIA, INCLUDING THOSE PRODUCING CARBAPENEMASE | 2022 |
|
RU2793587C1 |
REMEDY FOR TREATMENT OF INFECTIOUS DISEASES CAUSED BY MULTIPLE RESISTANT BACTERIA | 2006 |
|
RU2831350C2 |
PREPARATION FOR TREATING INFECTIOUS DISEASES CAUSED BY MULTIRESISTANT BACTERIA | 2006 |
|
RU2377985C2 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF INFECTIOUS DISEASES CAUSED BY MULTI-RESISTANT BACTERIA | 2011 |
|
RU2455989C1 |
CYCLIC BORONIC ACID ESTER DERIVATIVES AND THERAPEUTIC USE THEREOF | 2011 |
|
RU2599791C2 |
ORALLY ADMINISTERED COMBINATIONS OF BETA-LACTAM ANTIBIOTICS AND AVIBACTAM DERIVATIVES FOR TREATING BACTERIAL INFECTIONS | 2020 |
|
RU2825281C1 |
INTENDED FOR INJECTION COMPOSITIONS FOR OVERCOMING BETA-LACTAMASE-MEDIATED RESISTANCE TO ANTIBIOTICS WITH APPLICATION OF BETA-LACTAMASE INHIBITOR | 2005 |
|
RU2397768C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING BETA-LACTAM ANTIBIOTIC, SULBACTAM AND BETA-LACTAMASE INHIBITOR | 2011 |
|
RU2569059C2 |
ANTIBACTERIAL COMPOSITIONS | 2013 |
|
RU2646798C2 |
COMBINATION THERAPY FOR TREATING NOSOCOMIAL PNEUMONIA | 2014 |
|
RU2684112C2 |
Authors
Dates
2024-09-02—Published
2023-08-30—Filed